Neurological manifestations of vasculitis and primary central nervous system vasculitis;Neurologische manifestationen von vaskulitiden und primäre zns-vaskulitis

Zeitschrift fur Rheumatologie

Volumn 71, Issue 7, 2012, Pages 551-563

  Magnus, T ^a   Melms, A ^b   Kotter I ^b   Holle, J U ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Klinikum Bad Bramstedt   (Germany)

Author keywords

Ischemic cerebral infarct; Meningitis; Polyneuropathy; Primary vasculitis of the central nervous system; Vasculitides

Indexed keywords

CYCLOPHOSPHAMIDE; GLUCOCORTICOID;

ANCA ASSOCIATED VASCULITIS; ANTIVIRAL THERAPY; ARTICLE; BRAIN INFARCTION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; DISEASE SEVERITY; IMMUNOSUPPRESSIVE TREATMENT; NEUROLOGICAL COMPLICATION; PERIPHERAL NEUROPATHY; POLYARTERITIS NODOSA; PRIMARY CENTRAL NERVOUS SYSTEM VASCULITIS; REMISSION; SMALL VESSEL VASCULITIS; VASCULITIS;

DIAGNOSIS, DIFFERENTIAL; HUMANS; NERVOUS SYSTEM DISEASES; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 84866885400     PISSN: 03401855     EISSN: 14351250     Source Type: Journal    
DOI: 10.1007/s00393-012-0957-0     Document Type: Article

References (48)

1. Al-Araji A, Kidd DP (2009) Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. Lancet Neurol 8:192-204
2. Alreshaid AA, Powers WJ (2003) Prognosis of patients with suspected primary CNS angiitis and negative brain biopsy. Neurology 61:831-833
3. Arend WP, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 Criteria for the classification of Takayasu Arteritis. Arthritis Rheum 33:1129-1134
4. Birnbaum J, Hellmann DB (2009) Primary angiitis of the central nervous system. Arch Neurol 66:704-709
5. Bley TA, Weiben O, Uhl M et al (2005) Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging. Arthritis Rheum 52:2470-2477
6. Calabrese LH, Mallek JA (1988) Primay angiitis of the central nervous system. Report of 8 new cases, review of the literature and proposal for diagnostic criteria. Medicine 67:20-39
7. Caselli RJ, Daube RJ, Hunder GG et al (1988) Peripheral neuropathic syndromes in giant cell (temproal) arteritis. Neurology 38:685-689
8. Cattaneo L, Chierici E, Pavone L et al (2007) Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis. J Neurol Neurosurg Psychiatry 78:1119-1123
9. Dammaco F, Tucci FA, Lauletta G et al (2010) Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. Blood 116:343-353
10. De Groot K, Schmidt DK, Arlt AC et al (2001) Standardized neurologic evaluations of 128 patients with Wegener's granulomatosis. Arch Neurol 58:1215-1221
11. De Vita S, Quartuccio L, Isola M et al (2012) A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum 64(3):843-853
12. Drachman DA (2001) Neurological complications of Wegener's granulomatosis. Arch Neurol 58:1215-1221
13. Ferri C, Mascia MT (2006) Cryoglobulinemic vasculitis. Curr Opin Rheumatol 18:54-63
14. Garcia-Garcia J, Ayo-Martin O, Argandona-Palacios L et al (2011) Vertebral artery halo sign in patients with stroke. A key clue for the prompt diagnosis in giant cell arteritis. Stroke 42:3287-3290
15. Garzoni L, Vanoni F, Rizzi M et al (2009) Nervous system dysfunction in Henoch-Schönlein syndrome: systematic review of the literature. Rheumatology 48:1524-1529
16. Gonzalez-Gay MA, Blanco R, Rodirguez-Valverde V et al (1998) Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 41:1497-1504
17. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J et al (2000) Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine 79:283-292
18. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Gomez-Acebo I et al (2009) Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis. Medicine 88:227-235
19. Hajj-Ali RA, Singhal AB, Benseler S et al (2011) Primary angiitis of the CNS. Lancet Neurol 10:561-572
20. Hirohata S (2008) Histopathology of central nervous system lesions in Behçet's disease. J Neurol Sci 267:41-47
21. Holle JU, Wieczorek S, Gross WL (2010) The future of ANCA-associated vasculitis. Rheum Dis Clin North Am 36:609-621
22. Holle JU, Gross WL (2011) Neurological involvement in Wegener's granulomatosis. Curr Opin Rheumatol 23:7-11
23. Holle JU, Dubrau C, Herlyn K et al (2012) Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations. Ann Rheum Dis 71:327-333
24. Horger M, Maksimovic O, Kotter I, Ernemann U (2008) Neuro-Behçet's disease: MR-imaging findings. Rofo 180:691-697
25. Hunder GG, Bloch DA, Michel BA et al (1990) The American College of Rheumatology 1990 Criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122-1128
26. Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides. Proposal of an International Consensus Conference. Arthritis Rheum 37:187-192
27. Johnston SL, Lock RJ, Gompels MM (2002) Takayasu arteritis: a review. J Clin Pathol 55:481-486
28. Kotter I, Gunaydin I, Batra M et al (2006) CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications: results of a retrospective analysis of 117 cases. Clin Rheumatol 25:482-486
29. Lightfoot RW, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 Criteria for the classification of Polyarteritis nodosa. Arthritis Rheum 33:1088-1093
30. Mahr AD, Jover JA, Spiera RF et al (2007) Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 56:2789-2797
31. Maksimowicz-McKinnon K, Clark TM, Hofman GS (2009) Takayasu arteritis and giant cell arteritis. A spectrum within the same disease? Medicine 88:221-226
32. Miller DV, Salvarani C, Hunder GG et al (2009) Biopsy findings of primary angiitis of the central nervous system. Am J Surg Pathol 33:35-43
33. Bremer JP, Metzler C, Hellmich B et al (2010) Evaluation of 150 monocentric patients with Churg Strauss syndrome in an interdisciplinary approach. Ann Rheum Dis 69(Suppl 3):223
34. Mukhtyar C, Guillevin L, Cid MC et al (2009) EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 68:318-323
35. Mukhtyar C, Guillevin L, Cid MC et al (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68:310-317
36. Pagnoux C, Seror R, Henegar C et al (2012) Clinical features and outcome in 348 patients with polyarteritis nodosa. Arthritis Rheum 62:616-626
37. Reinhold-Keller E; Herlyn K, Wagner-Bastmeyer R et al (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53:93-99
38. Ringleb PA, Strittmacher EI, Loewer M et al (2005) Cerebrovascular manifestations of Takayasu arteritis in Europe. Rheumatology 44:1012-1015
39. Salvarani C, Brown RD, Hunder GG (2012) Adult primary central nervous system vasculitis: an update. Curr Opin Rheumatol 24:46-52
40. Salvarani C, Brown RD, Calamia KT et al (2007) Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 62:442-451
41. Salvarani C, Giannini C, Miller DV et al (2006) Giant cell arteritis: involvement of intracranial arteries. Arthritis Rheum 55:985-989
42. Saulsbury FT (2007) Clinical update: Henoch-Schönlein pupura. Lancet 369:976-978
43. Schäfer VS, Zwerina J (2012) Biologic treatment of large-vessel vasculitides. Curr Opin Rheumatol 1:31-37
44. Schmidley JW (2000) Central nervous system angiitis. Butterworth- Heinemann, Boston
45. Siva A, Saip S (2009) The spectrum of nervous system involvement in Behçet's syndrome and its differential diagnosis. J Neurol 256:513-529
46. Stone JH, Merkel PA, Spiera R et al (2010) Rituximab versus cyclophopshamide for ANCA-associated vasculitis. N Engl J Med 363:221-232
47. Suppiah R, Hadden RD, Arden NK et al (2011) Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials. Rheumatology 50:2214-2222
48. Younger DS, Hays AP, Brust JC et al (1988) Granulomatous angiitis of the brain. An inflammatory reaction of diverse etiology. Arch Neurol 45:514-518